Analysis of hemostasis indicators in patients with coronavirus infection

D.M.Xodjaniyazova SH.A.Babadjanova, D.B.Mirazimov, Qurbonova Z.Ch A.B.Saidov, O.A.Muminov, D.A.Tojiboyeva

dc.contributor.author	D.M.Xodjaniyazova SH.A.Babadjanova, D.B.Mirazimov, Qurbonova Z.Ch A.B.Saidov, O.A.Muminov, D.A.Tojiboyeva
dc.date.accessioned	2022-12-03T06:18:13Z
dc.date.available	2022-12-03T06:18:13Z
dc.date.issued	2021-03-05
dc.identifier.issn	1583-6258,
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/4730
dc.description.abstract	COVID-19 is a systemic infection, one of the most common complications of which is hypercoagulability. Blood clotting disorders are quite common among patients with severe course of coronavirus infection	en_US
dc.language.iso	en	en_US
dc.publisher	Romania	en_US
dc.relation.ispartofseries	Issue;4, 2021
dc.subject	PT, PTI, INR, APTT, fibrinogen, adhesion, aggregation,retraction of platelets.	en_US
dc.title	Analysis of hemostasis indicators in patients with coronavirus infection	en_US
dc.type	Article	en_US